The Discounted Cash Flow (DCF) valuation of Infinity Pharmaceuticals Inc (INFI) is (57.43) USD. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on DCF is -128580.1%.
Based on the latest price of 0.04 USD and our DCF valuation, Infinity Pharmaceuticals Inc (INFI) is a sell. selling INFI stocks now will result in a potential gain of 128580.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 6.4% | 5.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (407.85) - (31.67) | (57.43) |
| Upside | -912509.4% - -70942.0% | -128580.1% |